Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of Cognitive-Behavioral Therapy Targeting Severe Fatigue Following Coronavirus Disease 2019: Results of a Randomized Controlled Trial.
Kuut TA, Müller F, Csorba I, Braamse A, Aldenkamp A, Appelman B, Assmann-Schuilwerve E, Geerlings SE, Gibney KB, Kanaan RAA, Mooij-Kalverda K, Hartman TCO, Pauëlsen D, Prins M, Slieker K, van Vugt M, Keijmel SP, Nieuwkerk P, Rovers CP, Knoop H. Kuut TA, et al. Among authors: muller f. Clin Infect Dis. 2023 Sep 11;77(5):687-695. doi: 10.1093/cid/ciad257. Clin Infect Dis. 2023. PMID: 37155736 Free PMC article. Clinical Trial.
Condition or cognition? Mechanism of change in fatigue in a randomized controlled trial of graded exercise therapy or cognitive behavior therapy for severe fatigue in patients with advanced cancer.
Poort H, Müller F, Bleijenberg G, Verhagen SAHHVM, Verdam MGE, Nieuwkerk PT, Knoop H. Poort H, et al. Among authors: muller f. J Consult Clin Psychol. 2021 Sep;89(9):731-741. doi: 10.1037/ccp0000670. Epub 2021 Aug 26. J Consult Clin Psychol. 2021. PMID: 34435804 Clinical Trial.
A randomised controlled trial testing the efficacy of Fit after COVID, a cognitive behavioural therapy targeting severe post-infectious fatigue following COVID-19 (ReCOVer): study protocol.
Kuut TA, Müller F, Aldenkamp A, Assmann-Schuilwerve E, Braamse A, Geerlings SE, Gibney KB, Kanaan RAA, Nieuwkerk P, Olde Hartman TC, Pauëlsen D, Prins M, Slieker K, Van Vugt M, Bleeker-Rovers CP, Keijmel SP, Knoop H. Kuut TA, et al. Among authors: muller f. Trials. 2021 Dec 2;22(1):867. doi: 10.1186/s13063-021-05569-y. Trials. 2021. PMID: 34857010 Free PMC article.
A research agenda for post-COVID-19 fatigue.
Verveen A, Müller F, Lloyd A, Moss-Morris R, Omland T, Penninx B, Raijmakers RPH, van der Schaaf M, Sandler CX, Stavem K, Wessely S, Wyller VBB, Nieuwkerk P, Knoop H. Verveen A, et al. Among authors: muller f. J Psychosom Res. 2022 Mar;154:110726. doi: 10.1016/j.jpsychores.2022.110726. Epub 2022 Jan 22. J Psychosom Res. 2022. PMID: 35086054 Free PMC article. No abstract available.
Reply to Crawford and Biere-Rafi et al.
Kuut TA, Müller F, Nieuwkerk P, Rovers CP, Knoop H. Kuut TA, et al. Among authors: muller f. Clin Infect Dis. 2023 Oct 5;77(7):1075-1077. doi: 10.1093/cid/ciad398. Clin Infect Dis. 2023. PMID: 37387679 No abstract available.
3,141 results